Search Options Stock News and Analysis

https://www.schaeffersresearch.com/content/news/2019/10/28/omeros-shorts-squeezed-as-stock-pops

10/28/2019 2:24 PM

Omeros Corporation (NASDAQ:OMER) earlier said it initiated the rolling submission process for a Biologics License Application (BLA) to the U.S. Food and Drug Administration for narsoplimab, its leadin...

Education Stock Halted During Earnings Collapse

https://www.schaeffersresearch.com/content/news/2019/07/31/education-stock-halted-during-earnings-collapse

7/31/2019 3:15 PM

Stocks mostly traded near breakeven today, though the Dow was last seen sharply lower after Fed Chair Jerome Powell suggested more rate cuts may not be coming. Three names to watch in the meantime ar...

Calls Pop as Drug Stock Gets FDA Boost

https://www.schaeffersresearch.com/content/options/2019/07/11/calls-pop-as-drug-stock-gets-fda-boost

7/11/2019 2:46 PM

The shares of Omeros Corporation (NASDAQ:OMER) are up 2.3% to trade at $15.56 today, and earlier traded as high as $16.88. This comes after the Food and Drug Administration (FDA) agreed on the main ...

3 Biotech Stocks Surging Today

https://www.schaeffersresearch.com/content/news/2018/05/11/3-biotech-stocks-surging-today

5/11/2018 2:48 PM

Stocks are mostly higher today, with the Dow heading towards its seventh straight win. President Trump spoke at 2 p.m. ET today regarding drug prices, revealing a plan to lower prescription costs. D...

Biotech Stock Bursting After Congressional Spending Bill

https://www.schaeffersresearch.com/content/news/2018/03/22/biotech-stock-bursting-after-congressional-spending-bill

3/22/2018 10:02 AM

The shares of eye drug maker Omeros Corporation (NASDAQ:OMER) are skyrocketing this morning, thanks to the latest spending bill from Congress. Specific language in the package's Medicare reimbursemen...

PEOPLE ALSO SEARCH FOR